Decipher Labs Share Price

  • 17.10-0.06 (-0.34%)
  • Volume: 20,417
BSE
  • Closed
  • Last Updated On: 29 Aug, 2024, 03:56 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Decipher Labs Share Pri...

  • 17.10-0.06 (-0.34%)
  • Volume: 20,417
Advertisment

Decipher Labs share price insights

View All

  • Company has become debt free for the first time since last 5 years. (Source: Consolidated Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 77.34% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

  • Stock gave a 3 year return of -47.69% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

  • Stock generated -47.69% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)

  • Decipher Labs Ltd. share price moved down by -0.34% from its previous close of Rs 17.16. Decipher Labs Ltd. stock last traded price is 17.10

    Share PriceValue
    Today/Current/Last-17.10
    Previous Day-17.16

InsightsDecipher Labs

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		78.79
    EPS - TTM
    (₹)    		0.22
    MCap
    (₹ Cr.)    		17.27
    Sectoral MCap Rank
    		156
    PB Ratio
    (x)    		0.79
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month0.23
    3 Months0.35
    6 Months0.18
    1 Year0.21
    3 Years0.13

    		0.23
    VWAP
    (₹)    		17.16
    52W H/L
    (₹)
    25.75 / 14.44

    Decipher Labs Share Price Returns

    1 Day-0.34%
    1 Week-2.68%
    1 Month-6.51%
    3 Months14.84%
    1 Year8.78%
    3 Years-47.38%
    5 Years-26.61%

    ET Stock ScreenersTop Score Companies

    Check whether Decipher Labs belongs to analysts' top-rated companies list?

    View Stock Screeners

    Decipher Labs News & Analysis

    View all Decipher Labs Share News & Announcements

    Decipher Labs Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Decipher Labs Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Decipher Labs Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 77.34% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income7.6010.868.297.639.51
      Total Income Growth (%)-30.0431.058.63-19.80-4.19
      Total Expenses6.249.498.279.779.76
      Total Expenses Growth (%)-34.2114.65-15.300.12-29.05
      EBIT1.361.380.01-2.14-0.24
      EBIT Growth (%)-1.250.00---
      Profit after Tax (PAT)0.951.200.01-1.94-0.95
      PAT Growth (%)-21.440.00---
      EBIT Margin (%)17.8712.660.17-28.03-2.56
      Net Profit Margin (%)12.4611.090.13-25.46-9.97
      Basic EPS (₹)0.941.190.01-1.92-0.94
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income0.393.360.180.010.01
      Total Income Growth (%)-88.541,769.693,496.000.00-96.25
      Total Expenses0.513.230.090.100.11
      Total Expenses Growth (%)-84.193,634.53-8.94-13.94-76.60
      EBIT-0.130.130.09-0.09-0.11
      EBIT Growth (%)-198.8236.91---
      Profit after Tax (PAT)-0.130.130.09-0.07-0.12
      PAT Growth (%)-199.8541.01---
      EBIT Margin (%)-32.743.8051.84-1,802.00-2,110.00
      Net Profit Margin (%)-33.973.9051.67-1,494.00-2,444.00
      Basic EPS (₹)-0.130.130.09-0.07-0.12
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue36.3052.9473.0056.2124.26
      Total Revenue Growth (%)-31.45-27.4729.87131.70201.07
      Total Expenses37.5154.8660.6454.0622.79
      Total Expenses Growth (%)-31.63-9.5312.16137.20199.24
      Profit after Tax (PAT)-1.68-2.6811.381.401.10
      PAT Growth (%)--123.56711.6227.40171.56
      Operating Profit Margin (%)-2.76-3.2719.645.899.12
      Net Profit Margin (%)-4.67-5.8817.422.524.58
      Basic EPS (₹)-1.66-2.6611.271.391.09
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue3.550.841.031.121.44
      Total Revenue Growth (%)323.71-18.96-7.68-22.02-78.84
      Total Expenses3.531.240.681.021.27
      Total Expenses Growth (%)185.3982.67-33.68-19.64-80.21
      Profit after Tax (PAT)0.02-2.620.360.100.17
      PAT Growth (%)--826.28274.64-42.74-55.43
      Operating Profit Margin (%)0.71-49.0636.2112.1211.76
      Net Profit Margin (%)0.66-323.1436.469.8511.80
      Basic EPS (₹)0.02-2.590.360.100.17

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • All Debts Paid-off

        Company has become debt free for the first time since last 5 years. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets33.6328.1641.9538.7235.38
      Total Assets Growth (%)19.42-32.868.349.44457.90
      Total Liabilities-4.9617.7825.03-
      Total Liabilities Growth (%)-100.00-72.13-28.96--
      Total Equity21.8623.2124.1713.6912.56
      Total Equity Growth (%)-5.81-3.9676.558.97397.13
      Current Ratio (x)2.105.013.441.300.99
      Total Debt to Equity (x)0.000.040.430.640.90
      Contingent Liabilities0.00----
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets12.768.9911.6011.4011.65
      Total Assets Growth (%)41.94-22.501.75-2.1599.49
      Total Liabilities3.830.090.080.240.58
      Total Liabilities Growth (%)4,155.5612.50-66.67-58.62-82.63
      Total Equity8.938.9011.5211.1611.07
      Total Equity Growth (%)0.34-22.743.230.81342.80
      Current Ratio (x)1.042.1532.3611.775.36
      Total Debt to Equity (x)0.000.000.000.010.02
      Contingent Liabilities0.00----

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 1.79 cr for investing activities which is an YoY decrease of 58.11%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities4.85-1.568.261.83-15.18
      Net Cash used in Investing Activities-1.79-4.28-0.45-0.31-0.12
      Net Cash flow from Financing Activities-1.17-2.151.303.9916.36
      Net Cash Flow1.90-7.998.435.511.17
      Closing Cash & Cash Equivalent9.317.4215.416.981.47
      Closing Cash & Cash Equivalent Growth (%)25.56-51.86120.89375.06391.60
      Total Debt/ CFO (x)0.00-0.611.254.78-0.74
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities-0.03-0.080.550.27-0.01
      Net Cash used in Investing Activities-0.09-0.38-0.19-0.07
      Net Cash flow from Financing Activities---0.14-0.090.09
      Net Cash Flow-0.030.010.03-0.010.01
      Closing Cash & Cash Equivalent0.030.060.050.020.03
      Closing Cash & Cash Equivalent Growth (%)-52.8518.07146.63-34.8068.18
      Total Debt/ CFO (x)0.000.000.000.50-22.37

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)-7.66-11.5547.1010.248.76
      Return on Capital Employed (%)-4.54-6.1741.6015.3017.41
      Return on Assets (%)-4.98-9.5227.133.623.11
      Interest Coverage Ratio (x)-2.49-2.4928.742.893.03
      Asset Turnover Ratio (x)1.161.300.04143.4967.79
      Price to Earnings (x)-8.90-5.344.7024.1517.30
      Price to Book (x)0.680.622.212.471.52
      EV/EBITDA (x)-10.36-7.393.538.6810.51
      EBITDA Margin (%)-1.50-2.3320.977.3711.43
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)0.26-29.393.120.861.51
      Return on Capital Employed (%)0.28-4.463.101.051.51
      Return on Assets (%)0.18-29.113.100.841.44
      Interest Coverage Ratio (x)0.000.000.006.610.00
      Asset Turnover Ratio (x)0.320.080.098.5612.22
      Price to Earnings (x)666.67-5.48149.25357.14113.64
      Price to Book (x)1.671.614.643.031.72
      EV/EBITDA (x)375.09-41.99130.96212.15112.51
      EBITDA Margin (%)1.12-41.9741.2716.3712.01

    Financial InsightsDecipher Labs

    • Income (P&L)
    • Balance Sheet
    • Cash Flow

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 77.34% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

      • All Debts Paid-off

        Company has become debt free for the first time since last 5 years. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 1.79 cr for investing activities which is an YoY decrease of 58.11%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Decipher Labs Peer Comparison

    • Decipher Labs Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of -47.69% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated -47.69% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of -47.69% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated -47.69% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Decipher Labs78.790.79-7.66-4.54-4.98-13.44-2.76-4.67-1.662.100.000.00
          Abbott India51.2117.1532.4742.3323.1211.4427.8720.53565.282.420.000.00
          GSK Pharma73.3026.3933.4247.3316.705.5527.8417.0841.141.840.000.00
          Pfizer44.9630.3633.2422.9327.210.7628.2740.85100.385.040.000.00
          AstraZeneca173.8823.4122.6828.3414.9817.0115.7712.4664.602.610.000.00
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Sanofi India
          • P&G Health
          • Novartis India
          • Kerala Ayurveda

          Choose from Stocks

            See All Parameters

          Peers InsightsDecipher Labs

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of -47.69% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated -47.69% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Decipher Labs Shareholding Pattern

          • QOQ Change

          • Total Shareholdings

          • Loading...
            Showing Decipher Labs Shareholding as on 30 Jun 2024
            Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
            Promoters16.4316.4316.4316.43
            Pledge0.000.000.000.00
            FII0.000.000.000.00
            DII0.000.000.000.00
            Mutual Funds0.000.000.000.00
            Others83.5783.5783.5783.57
          • Showing Shareholding as on 30 Jun 2024
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters16,59,07516.43 %0.00
            Pledge00.00 %0.00
            Others84,40,92583.57 %0.00

          MF Ownership

          MF Ownership details are not available.

          Top Searches:

          Decipher Labs News Decipher Labs Quarterly Results Decipher Labs Dividend Decipher Labs Q1 ResultsDecipher Labs Q2 ResultsDecipher Labs Q3 ResultsDecipher Labs Q4 Results

          Corporate Actions

          • Decipher Labs Board Meeting/AGM

          • Decipher Labs Dividends

          • Others
          • Meeting DateAnnounced onPurposeDetails
            Aug 14, 2024Aug 08, 2024Board MeetingQuarterly Results
            May 30, 2024May 21, 2024Board MeetingAudited Results
            Feb 14, 2024Feb 06, 2024Board MeetingQuarterly Results
            Nov 10, 2023Nov 02, 2023Board MeetingQuarterly Results
            Sep 30, 2023Sep 12, 2023AGMA.G.M.

          • Dividend announcements are not available.

          • No other corporate actions details are available.

          About Decipher Labs

          Decipher Labs Ltd., incorporated in the year 1986, is a Small Cap company (having a market cap of Rs 17.41 Crore) operating in Pharmaceuticals sector. Decipher Labs Ltd. key Products/Revenue Segments include Pharmaceutical Products and Other Operating Revenue for the year ending 31-Mar-2023. Show More

          • Executives

          • Auditors

          • SM

            Sushant Mohan Lal

            Executive Director
            JR

            Janaki Ram Ajjarapu

            Non Executive Director
            GV

            G Venkateswara Rao

            Independent Director
            LV

            Lakshmi Vijaya Nimmala

            Independent Director
            Show More
          • Ramanatham & Rao
            M Anandam & Co.

          Industry

          Pharma - MNC

          Key Indices Listed on

          -

          Address

          4th Floor, Plot No.94,Sagar Society,Road No.2,Hyderabad, Telangana - 500034

          Contact

          [email protected]

          http://www.decipherlabs.in

          More Details

          FAQs about Decipher Labs share

          • 1. What is Decipher Labs share price and what are the returns for Decipher Labs share?
            As on 29 Aug, 2024, 03:56 PM IST Decipher Labs share price was down by 0.34% basis the previous closing price of Rs 17.52. Decipher Labs share price was Rs 17.10. Return Performance of Decipher Labs Shares:
            • 1 Week: Decipher Labs share price moved down by 2.68%
            • 3 Month: Decipher Labs share price moved up by 14.84%
            • 6 Month: Decipher Labs share price moved down by 3.88%
          • 2. What is the CAGR of Decipher Labs?
            The CAGR of Decipher Labs is -10.36.
          • 3. What is the PE & PB ratio of Decipher Labs?
            The PE ratio of Decipher Labs stands at 78.33, while the PB ratio is 0.79.
          • 4. What is the market cap of Decipher Labs?
            Market Capitalization of Decipher Labs stock is Rs 17.27 Cr.
          • 5. What are the returns for Decipher Labs share?
            Return Performance of Decipher Labs Shares:
            • 1 Week: Decipher Labs share price moved down by 2.68%
            • 3 Month: Decipher Labs share price moved up by 14.84%
            • 6 Month: Decipher Labs share price moved down by 3.88%
          • 6. Who's the owner of Decipher Labs?
            Promoter owns 16.43, shares of Decipher Labs as on 30 Jun 2024
            • There is no change in promoter holding from 31 Mar 2024 to 30 Jun 2024
            • There is no change in Other investor holding from 31 Mar 2024 to 30 Jun 2024
          • 7. What has been highest price of Decipher Labs share in last 52 weeks?
            Decipher Labs share price saw a 52 week high of Rs 25.75 and 52 week low of Rs 14.44.
          • 8. What are the Decipher Labs quarterly results?
            On Consoldiated basis, Decipher Labs reported a total income and loss of Rs 7.60 Cr and Rs 0.95 respectively for quarter ending 2024-06-30. Total Income and loss for the year ending 2024-03-31 was Rs 36.30 Cr and Rs -1.68 Cr.
          • 9. What are the key metrics to analyse Decipher Labs Share Price?
            Decipher Labs share can be quickly analyzed on following metrics:
            • Stock's PE is 78.79
            • Price to Book Ratio of 0.79
          • 10. Which are the key peers to Decipher Labs?
            Top 8 Peers for Decipher Labs are Kerala Ayurveda Ltd., Novartis India Ltd., Procter & Gamble Health Ltd., Sanofi India Ltd., AstraZeneca Pharma India Ltd., Pfizer Ltd., GlaxoSmithKline Pharmaceuticals Ltd. and Abbott India Ltd.

          Trending in Markets

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Decipher Labs Share Price
          The Economic Times